Fairmount Funds Management LLC Bicycle Therapeutics PLC Transaction History
Fairmount Funds Management LLC
- $504 Million
- Q2 2024
A detailed history of Fairmount Funds Management LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Fairmount Funds Management LLC holds 1,069,199 shares of BCYC stock, worth $23.7 Million. This represents 4.29% of its overall portfolio holdings.
Number of Shares
1,069,199Holding current value
$23.7 Million% of portfolio
4.29%Shares
1 transactions
Others Institutions Holding BCYC
# of Institutions
111Shares Held
40.7MCall Options Held
3.4KPut Options Held
12.4K-
Baker Bros. Advisors LP New York, NY9.4MShares$209 Million2.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.49MShares$77.5 Million2.32% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.25MShares$50 Million0.69% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.12MShares$47.1 Million6.34% of portfolio
-
Armistice Capital, LLC New York, NY1.97MShares$43.8 Million0.52% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $659M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...